期刊文献+

878株鲍曼不动杆菌的耐药分析及流行调查 被引量:8

Resistance Analysis and Epidemiological Survey of 878 Acinetobacter Baumannii Solates
下载PDF
导出
摘要 目的调查鲍曼不动杆菌的分布、耐药变迁,分析耐药谱,为临床治疗提供有效的实验室依据,防范院内感染.方法回顾性分析2008年1月至2011年6月临床分离的鲍曼不动杆菌的分布、耐药情况及以氨曲南(ATM、A)、氨苄西林(AMP、P)、环丙沙星(CIP、C)、美罗培南(MEM、M)、头孢他(CAZ、F),亚胺培南(IPM、I)组合的耐药谱表型.结果 3 a半共检出鲍曼不动杆菌878株,呼吸道标本占84%;ICU为主要分布科室;感染率逐年上升.鲍曼不动杆菌对分析的16种临床常用抗生素的耐药率逐年上升,其中亚胺培南和美罗培南的耐药率分别高达:84.4%、87.5%.经抗生素耐药谱统计共发现67种耐药表型在我院流行,其中以抗生素谱:(1)"APC-FI"(ATM、AMP、CIP、CAZ、IPM:均耐药,MEM:未测定);(2)"APCMFI"(ATMAMPCIPMEMCAZIPM均耐药")为主,感染率分别为:19%及15%.结论鲍曼不动杆菌感染率逐年升高,对常用抗生素耐药率继续呈现上升趋势,耐药谱"APC-FI"、"APCMFI"在我院广泛流行. Objective To provide effective laboratorial proof and control hospital infection by investigating the distribution and drug resistance of Acinetobacter baumannii and analyzing resistance profiles.Method The distribution,drug resistance and resistance profiles including Aztreonam(A),Ampicillin(P),Ciprofloxacin(C),Meropenem(M),Ceftazidime(F)and Imipenem(I)of Acinetobacter baumannii clinical isolates in our hospital from Jan.2008 to Jun.2011 were reviewed and analyzed by WHONET 5.5 software.Results 878 Acinetobacter baumannii strains were found,in which 84% were respiratory tract specimens,and most strains were in ICU.Acinetobacter baumannii 's infection rate and drug resistance rates to 16 clinical common antibiotics was rising year by year,particularly resistance rates to Imipenem and Meropenem were up to 84.4% and 87.5% respectively.Resistance profiles of Acinetobacter baumannii had 67 kinds,in which three phenotypes:(1) "APC-FI"(ATM,AMP,CIP,CAZ,IPM:all resistance,MEM: not determined),(2) "APCMFI"(ATM,AMP,CIP,MEM,IPM all resistance were mainly phenotypes.The infection rate of the two phenotypes was 19%,and 15%,respectively.Conclusion Infection rate of Acinetobacter baumannii is rising year by year,its resistant rates to common antibiotics show an upward trend and new phenotype start to prevalent.
出处 《昆明医学院学报》 2011年第9期92-95,共4页 Journal of Kunming Medical College
关键词 鲍曼不动杆菌 耐药 抗生素 耐药谱 Acinetobacter baumannii Drug-resistance Antibiotics Resistance profies
  • 相关文献

参考文献6

  • 1SILVANA V S,DANIELA D S M,JULIANAC,et al.Indications of carbapenem ersistance evolution through heteroresistance as an intermedia stage in Acinetobacter baumannii after carbapenem administration[J].Rev InstMed trop S Paulo,2009,51 (2):111-113.
  • 2ELISABETTA N,LAURA S,GIULIA F,et al.Concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii[J].BMC Microbiology,2009,9:270.
  • 3A report from the NNIS System.National nosocomial infections surveilance (NN1S) system report,data sununary from january1992 through june2003,issued august 2003[J].Am J infect Control,2003,31:481-498.
  • 4王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 5张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 6王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237

二级参考文献36

  • 1王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 2Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
  • 3Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
  • 4Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
  • 5Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
  • 6Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
  • 7Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
  • 8Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York.- citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31 : 101-106.
  • 9Kuo L, Teng L, Yu C, et al. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol, 2004, 42: 1759-1763.
  • 10Zarrulli R, Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergency of carbapenem resistance. J Clin Microbiol, 2004, 42: 946-953.

共引文献537

同被引文献70

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部